Calcium-calmodulin signaling induced by epithelial cell differentiation upregulates BRAK/CXCL14 expression via the binding of SP1 to the BRAK promoter region

Biochemical and Biophysical Research Communications

Volumn 420, Issue 2, 2012, Pages 217-222

  Ikoma, Takeharu ^a   Ozawa, Shigeyuki ^a   Suzuki, Kenji ^a   Kondo, Tadanori ^a   Maehata, Yojiro ^a   Lee, Masaichi Chang il ^a   Hata, Ryu Ichiro ^b   Kubota, Eiro ^a  

^a KANAGAWA DENTAL COLLEGE   (Japan)

^b Oral Health Science Research Center   (Japan)

Author keywords

Chemokine BRAK CXCL14; Differentiation; Epithelial cell

Indexed keywords

CALCIUM; CALMODULIN; CHLORPROMAZINE; CXCL14 CHEMOKINE; INVOLUCRIN; MESSENGER RNA; STEFIN A; TRANSCRIPTION FACTOR SP1;

AMINO ACID SEQUENCE; ARTICLE; CALCIUM SIGNALING; CELL CONTACT; CELL DENSITY; CELL DIFFERENTIATION; CELL STIMULATION; CONTROLLED STUDY; EPITHELIUM CELL; GENE EXPRESSION; GENE SEQUENCE; HUMAN; HUMAN CELL; IMMUNOHISTOCHEMISTRY; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN BINDING; SIGNAL TRANSDUCTION; UPREGULATION;

CALCIUM; CALMODULIN; CELL COMMUNICATION; CELL COUNT; CELL DIFFERENTIATION; CHEMOKINES, CXC; CHLORPROMAZINE; CYSTATIN A; EPITHELIAL CELLS; GENE EXPRESSION REGULATION; HUMANS; PROMOTER REGIONS, GENETIC; SIGNAL TRANSDUCTION; SP1 TRANSCRIPTION FACTOR; TRANSGLUTAMINASES; TUMOR CELLS, CULTURED; UP-REGULATION;

EID: 84862817328     PISSN: 0006291X     EISSN: 10902104     Source Type: Journal    
DOI: 10.1016/j.bbrc.2012.01.157     Document Type: Article

References (29)

1. S. Papini, D. Cecchetti, D. Campani, Fitzgerald W, Grivel JC, Chen S, Margolis L, Revoltella RP, Isolation and clonal analysis of human epidermal keratinocyte stem cells in long-term culture, Stem Cells 21 (2003) pp. 481-494.
2. Ro S., Rannala B. Evidence from the stop-EGFP mouse supports a niche-sharing model of epidermal proliferative units. Exp. Dermatol. 2005, 14:838-843.
3. L. Alonso, E. Fuchs, Stem cells of the skin epithelium, Proc. Natl. Acad. Sci. USA 30 (Suppl. 1) (2003) pp. 11830-11835.
4. Pillai S., Bikle D.D., Mancianti M.L., Cline P., Hincenbergs M. Calcium regulation of growth and differentiation of normal human keratinocytes: modulation of differentiation competence by stages of growth and extracellular calcium. J. Cell. Physiol. 1990, 143:294-302.
5. Charest J.L., Jennings J.M., King W.P., Kowalczyk A.P., García A.J. Cadherin-mediated cell-cell contact regulates keratinocyte differentiation. J. Invest. Dermatol. 2009, 129:564-572.
6. Steven A.C., Steinert P.M. Protein composition of cornified cell envelopes of epidermal keratinocytes. J. Cell Sci. 1994, 107:693-700.
7. Ozawa S., Kato Y., Komori R., Maehata Y., Kubota E., Hata R. BRAK/CXCL14 expression suppresses tumor growth in vivo in human oral carcinoma cells. Biochem. Biophys. Res. Commun. 2006, 348:406-412.
8. Shellenberger T.D., Wang M., Gujrati M., Jayakumar A., Strieter R.M., Burdick M.D., Ioannides C.G., Efferson C.L., El-Naggar A.K., Roberts D., Clayman G.L., Frederick M.J. BRAK/CXCL14 is a potent inhibitor of angiogenesis and a chemotactic factor for immature dendritic cells. Cancer Res. 2004, 64:8262-8270.
9. Sleeman M.A., Fraser J.K., Murison J.G., Kelly S.L., Prestidge R.L., Palmer D.J., Watson J.D., Kumble K.D. B cell- and monocyte-activating chemokine (BMAC), a novel non-ELR alpha-chemokine. Int. Immunol. 2000, 12:677-689.
10. Shurin G.V., Ferris R.L., Tourkova I.L., Perez L., Lokshin A., Balkir L., Collins B., Chatta G.S., Shurin M.R. Loss of new chemokine CXCL14 in tumor tissue is associated with low infiltration by dendritic cells (DC), while restoration of human CXCL14 expression in tumor cells causes attraction of DC both in vitro and in vivo. J. Immunol. 2005, 174:5490-5498.
11. Izukuri K., Suzuki K., Yajima N., Ozawa S., Ito S., Kubota E., Hata R. Chemokine CXCL14/BRAK transgenic mice suppress growth of carcinoma cell transplants. Transgenic Res. 2010, 19:1109-1117.
12. Frederick M.J., Henderson Y., Xu X., Deavers M.T., Sahin A.A., Wu H., Lewis D.E., El-Naggar A.K., Clayman G.L. In vivo expression of the novel CXC chemokine BRAK in normal and cancerous human tissue. Am. J. Pathol. 2000, 156:1937-1950.
13. Komori R., Ozawa S., Kato Y., Shinji H., Kimoto S., Hata R. Functional characterization of proximal promoter of gene for human BRAK/CXCL14, a tumor-suppressing chemokine. Biomed. Res. 2010, 31:123-131.
14. Ozawa S., Kato Y., Ito S., Komori R., Shiiki N., Tsukinoki K., Ozono S., Maehata Y., Taguchi T., Imagawa-Ishiguro Y., Tsukuda M., Kubota E., Hata R. Restoration of BRAK/CXCL14 gene expression by gefitinib is associated with antitumor efficacy of the drug in head and neck squamous cell carcinoma. Cancer Sci. 2009, 100:2202-2209.
15. Tessema M., Klinge D.M., Yingling C.M., Do K., Van Neste L., Belinsky S.A. Re-expression of CXCL14, a common target for epigenetic silencing in lung cancer, induces tumor necrosis. Oncogenesis 2010, 29:5159-5170.
16. Park B.Y., Hong C.S., Sohail F.A., Saint-Jeannet J.P. Developmental expression and regulation of the chemokine CXCL14 in Xenopus. Int. J. Dev. Biol. 2009, 53:535-540.
17. Cheng E.L., Li Y., Sugar J., Yue B.Y. Cell density regulated expression of transcription factor Sp1 in corneal stromal cultures. Exp. Eye Res. 2001, 73:17-24.
18. McKinnon C.M., Lygoe K.A., Skelton L., Mitter R., Mellor H. The atypical Rho GTPase RhoBTB2 is required for expression of the chemokine CXCL14 in normal and cancerous epithelial cells. Oncogenesis 2008, 27:6856-6865.
19. Hromas R., Broxmeyer H.E., Kim C., Nakshatri H., Christopherson K., Azam A., Hou Y.H. Cloning of BRAK, a novel divergent CXC chemokine preferentially expressed in normal versus malignant cells. Biochem. Biophys. Res. Commun. 1999, 255:703-706.
20. Tu C.L., Chang W., Bikle D.D. The role of the calcium sensing receptor in regulating intracellular calcium handling in human epidermal keratinocytes. J. Invest. Dermatol. 2007, 127:1074-1083.
21. Xie Z., Bikle D.D. The recruitment of phosphatidylinositol 3-kinase to the E-cadherin-catenin complex at the plasma membrane is required for calcium-induced phospholipase C-gamma1 activation and human keratinocyte differentiation. J. Biol. Chem. 2007, 282:8695-8703.
22. J.S. Wolf, Z. Chen, G. Dong, J.B. Sunwoo, C.C. Bancroft, D.E. Capo, N.T. Yeh, N. Mukaida, C. Van Waes, IL (interleukin)-1alpha promotes nuclear factor-kappaB and AP-1-induced IL-8 expression, cell survival, and proliferation in head and neck squamous cell carcinomas, Clin. Cancer Res. 7 (2001) pp. 1812-1820.
23. Roux P., Alfieri C., Hrimech M., Cohen E.A., Tanner J.E. Activation of transcription factors NF-kappaB and NF-IL-6 by human immunodeficiency virus type 1 protein R (Vpr) induces interleukin-8 expression. J. Virol. 2000, 74:4658-4665.
24. Mastronarde J.G., He B., Monick M.M., Mukaida N., Matsushima K., Hunninghake G.W. Induction of interleukin (IL)-8 gene expression by respiratory syncytial virus involves activation of nuclear factor (NF)-kappa B and NF-IL-6. J. Infect. Dis. 1996, 174:262-267.
25. Allinen M., Beroukhim R., Cai L., Brennan C., Lahti-Domenici J., Huang H., Porter D., Hu M., Chin L., Richardson A., Schnitt S., Sellers W.R., Polyak K. Molecular characterization of the tumor microenvironment in breast cancer. Cancer Cell 2004, 6:17-32.
26. Schwarze S.R., Luo J., Isaacs W.B., Jarrard D.F. Modulation of CXCL14 (BRAK) expression in prostate cancer. Prostate 2005, 64:67-74.
27. Pelicano H., Lu W., Zhou Y., Zhang W., Chen Z., Hu Y., Huang P. Mitochondrial dysfunction and reactive oxygen species imbalance promote breast cancer cell motility through a CXCL14-mediated mechanism. Cancer Res. 2009, 69:2375-2383.
28. Eckert R.L., Crish J.F., Efimova T., Dashti S.R., Deucher A., Bone F., Adhikary G., Huang G., Gopalakrishnan R., Balasubramanian S. Regulation of involucrin gene expression. J. Invest. Dermatol. 2004, 123:13-22.
29. Ozawa S., Ito S., Kato Y., Kubota E., Hata R. Human p38 delta MAP kinase mediates UV irradiation induced up-regulation of the gene expression of chemokine BRAK/CXCL14. Biochem. Biophys. Res. Commun. 2010, 396:1060-1064.